Furthermore, a study conducted in patients with advanced CKD and cancer has also shown an association between increased C-reactive protein and ESA hyporesponsiveness, thus underlining the role of chronic inflammation in determining ESA hyporesponsiveness in CKD [33]. The gene discussed is CRP; the disease is cancer.